EARLY HORMONE RECEPTOR-POSITIVE (HR-POSITIVE)

Clinical trials for EARLY HORMONE RECEPTOR-POSITIVE (HR-POSITIVE) explained in plain language.

Never miss a new study

Get alerted when new EARLY HORMONE RECEPTOR-POSITIVE (HR-POSITIVE) trials appear

Sign up with your email to follow new studies for EARLY HORMONE RECEPTOR-POSITIVE (HR-POSITIVE), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Test aims to spare breast cancer patients unnecessary chemo

Diagnosis Recruiting now

This study is evaluating a genomic test called EndoPredict that helps predict the 10-year risk of breast cancer returning. It aims to see if the test can reliably identify patients with a low risk of recurrence, so they can safely avoid chemotherapy and receive hormone therapy al…

Matched conditions: EARLY HORMONE RECEPTOR-POSITIVE (HR-POSITIVE)

Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Diagnosis

Last updated Mar 27, 2026 12:38 UTC

EARLY HORMONE RECEPTOR-POSITIVE (HR-POSITIVE)

Get alerted when new EARLY HORMONE RECEPTOR-POSITIVE (HR-POSITIVE) trials appear

Test aims to spare breast cancer patients unnecessary chemo